YOLFTbeta
30

Wuhan Huakang Century Medical Co. Ltd.

301235 · SHE · Healthcare / Medical Devices

29.65CNY-1.35 (-4.35%)

Price History

Full chart

Market Stats

Previous Close31.00
Open30.15
Day Range29.46 – 31.68
52-Week Range28.53 – 81.82
Volume4.81M
Market Cap5.66B
P/E (TTM)41.94
Forward P/E0.00
EPS0.97
Dividend Yield0.49%
Beta1.18
50-Day Avg43.54
200-Day Avg51.05

About

Wuhan Huakang Century Clean Technology Co., Ltd. provides purification system integration and sale of medical equipment and consumables services in China and internationally. It is also involved in the sale of medical equipment and consumables. In addition, the company offers integrated medical, laboratory integrated, and integrated electronic cleaning services, as well as medical consumables sales; purification system integration operation, and maintenance services. The company was formerly known as Wuhan Huakang Century Medical Co., Ltd. and changed its name to Wuhan Huakang Century Clean Technology Co., Ltd. in March 2025. Wuhan Huakang Century Clean Technology Co., Ltd. was founded in 2008 and is headquartered in Wuhan, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Xinqiang Xie
  • Employees2.07K
  • HeadquartersBuilding 3, No. 718 Gaoxin Avenue, Wuhan, China, 430223, China
  • Websitehttps://www.whhksj.com

Leadership

  • Mr. Xinqiang XieGM & Director · b. 1965
  • Ms. Yingchao ZhangFinancial Director & Accounting Supervisor · b. 1980
  • Mr. Zhan PengDeputy GM & Secretary · b. 1986
  • Mr. Hai WangDeputy General Manager · b. 1976
  • Ms. Jiali WangDeputy General Manager · b. 1977

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue602.15M761.82M860.81M1.19B1.60B1.71B2.29B
Growth (%)-+26.52%+12.99%+38.12%+34.71%+6.64%+33.87%
Cost of Revenue387.52M509.83M540.11M733.93M1.00B1.11B1.54B
Gross Profit214.63M252.00M320.70M454.98M600.66M596.18M750.50M
Gross Margin35.64%33.08%37.26%38.27%37.50%34.91%32.83%
Operating Expense120.14M150.41M189.90M299.28M399.93M379.09M478.31M
Operating Income94.49M101.59M130.79M155.69M200.73M217.10M272.19M
Operating Margin15.69%13.33%15.19%13.10%12.53%12.71%11.91%
EBITDA108.91M114.37M111.94M134.49M154.54M143.65M227.42M
EBITDA Margin18.09%15.01%13.00%11.31%9.65%8.41%9.95%
Net Income58.69M52.60M81.36M102.49M107.33M66.81M117.85M
Net Income Margin9.75%6.91%9.45%8.62%6.70%3.91%5.15%
R&D21.80M28.83M34.21M54.47M76.71M57.67M79.88M
R&D as % of Total Revenue3.62%3.78%3.97%4.58%4.79%3.38%3.49%
Interest Expense12.18M6.64M5.65M1.48M10.38M22.04M41.00M
Interest Expense % of Total Revenue2.02%0.87%0.66%0.12%0.65%1.29%1.79%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets793.93M891.45M1.24B2.37B2.89B4.23B4.30B
Total Liabilities335.83M380.75M646.71M715.65M1.14B2.42B2.36B
Total Equity458.10M510.70M592.06M1.65B1.75B1.80B1.91B
Cash55.92M149.43M235.62M252.29M267.94M1.05B522.89M
Net Debt----141.61M114.39M324.10M

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.13M84.65M44.59M-342.10M-187.36M147.56M-96.27M
Capital Expenditure2.01M3.80M6.53M124.96M547.41M111.81M59.25M
Free Cash Flow-6.14M80.84M38.06M-467.06M-734.77M35.76M-155.53M
Dividends Paid1.98M6.66M5.01M11.61M23.05M31.24M19.32M
FCF to OCF148.70%95.51%85.35%136.53%392.17%24.23%161.55%
Dividend Paid to FCF-32.17%8.23%13.18%-2.49%-3.14%87.36%-12.42%

Earnings

Report DateMar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate-----------------
EPS Actual-0.080.240.380.44-0.160.390.350.45-0.300.200.290.45-0.280.460.410.45-0.17
Surprise-----------------
Timing-----------------

Key Statistics & Ratios

Market Cap5.66B
Enterprise Value7.44B
Trailing P/E41.94
Forward P/E0.00
Price / Sales2.29
Price / Book3.44
EPS0.97
Book Value18.47
Revenue (TTM)2.47B
Gross Profit (TTM)773.44M
EBITDA206.34M
Profit Margin4.55%
Operating Margin5.35%
Return on Equity6.20%
Return on Assets2.51%
Shares Outstanding139.25M
Shares Float50.43M
Beta1.18
Dividend Yield0.49%
Dividend Rate0.20
Payout Ratio28.85%

Dividends

20261×
0.20May 29, 2026
20251×
0.05May 29, 2025
20241×
0.10May 30, 2024
20231×
0.13Jun 20, 2023
20221×
0.10May 18, 2022